Ledger.Open graph →
SEC Form D · filed June 12, 2025

SV8 Biotech Fund LP

Offering
—
Sold
—
Exemption
Rule 506(b)
Industry
Pooled Investment Fund
Location
LONDON, United Kingdom
Type
Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

James Costine · London, United KingdomExecKate Bingham · London, United KingdomExecEdward T. Van Brunt · Phoenix, AZExecJohn T. Dunlap, Iii · Phoenix, AZExecSv8 Bio GP LLP · London, United KingdomExec · DirectorSv Health Managers Llp · London, United KingdomExec · Director · PromoterGeorge B. Gebhardt · Dallas, TXExecCarlyon Knight-Evans · Mid-Levels West, Hong KongExecSv8 Bio GP LLP · London, United KingdomExec · DirectorSv Health Managers Llp · London, United KingdomExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗